Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 487

The DOI matches its Crossref record.

Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program

Gloeckler Ries, Lynn A., Reichman, Marsha E., Lewis, Denise Riedel, Hankey, Benjamin F., Edwards, Brenda K.·2003·The Oncologist

Abstract

Learning Objectives: After completing this course, the reader will be able to: Describe the role and significance of the NCI Surveillance and End Results (SEER) Program. Discuss the evolving changes in cancer mortality statistics in the U.S. Explain some of the important definitions of population science as they relate to cancer. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at CME.TheOncologist.com An overview of data on cancer at all sites combined and on selected, frequently occurring cancers is presented. Descriptive cancer statistics include average annual Surveillance, Epidemiology, and End Results (SEER) Program incidence, U.S. mortality and median age at diagnosis, and death for the period 1996–2000. Changes during the time period 1992–2000 are summarized by the annual percent change in SEER incidence and U.S. mortality data for this period. Five-year relative survival for selected cancers is examined by stage at diagnosis, based on data from 1990–1999. In addition, 5-year conditional survival for patients already surviving for 1–3 years after diagnosis is discussed as well as relative survival for other time periods. These measures may be more meaningful for clinical management and prognosis than 5-year relative survival from time of diagnosis. The likelihood of developing cancer during one's lifetime is 1 in 2 for males and 1 in 3 for females, based on 1998–2000 data. It is estimated that approximately 9.6 million people in the U.S. who have had a diagnosis of cancer are alive. Five-year relative survival varies greatly by cancer site and stage at diagnosis, and tends to increase with time since diagnosis. The median age at cancer diagnosis is 68 for men and 65 for women. The 5-year relative survival rate for persons diagnosed with cancer is 62.7%, with variation by cancer site and stage at diagnosis. For patients diagnosed with cancers of the prostate, female breast, corpus uteri, and urinary bladder, the relative survival rate at 8 years is over 75%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.8-6-541

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 487

Metadata

Authors
Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K.
Venue
The Oncologist
Published
2003-12-01
Volume
8
Issue
6
Pages
541-552
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2109688168
Cited by
487
References
0
FWCI
6.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program. https://app.cochat.ai/papers/10.1634/theoncologist.8-6-541
The paper
Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program. The Oncologist. https://doi.org/10.1634/theoncologist.8-6-541

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.